eCommons@AKU
Community Health Sciences

Department of Community Health Sciences

11-30-2020

Looking beyond the numbers: Quality assurance procedures in the
global network for women's and children's health research
maternal newborn health registry
Ana Garces
Emily MacGuire
Holly L. Franklin
Norma Alfaro
Gustavo Arroyo

See next page for additional authors

Follow this and additional works at: https://ecommons.aku.edu/pakistan_fhs_mc_chs_chs
Part of the Maternal and Child Health Commons, Pediatrics Commons, Quality Improvement
Commons, and the Women's Health Commons

Authors
Ana Garces, Emily MacGuire, Holly L. Franklin, Norma Alfaro, Gustavo Arroyo, Lester Figueroa,
Shivaprasad S. Goudar, Sarah Saleem, Fabian Esama, and Archana Patel

Garces et al. Reprod Health 2020, 17(Suppl 2):159
https://doi.org/10.1186/s12978-020-01009-3

Open Access

RESEARCH

Looking beyond the numbers: quality
assurance procedures in the Global Network
for Women’s and Children’s Health Research
Maternal Newborn Health Registry
Ana Garces1*, Emily MacGuire2, Holly L. Franklin2, Norma Alfaro1, Gustavo Arroyo1, Lester Figueroa1,
Shivaprasad S. Goudar3, Sarah Saleem4, Fabian Esamai5, Archana Patel6, Elwyn Chomba7, Antoinette Tshefu8,
Rashidul Haque9, Jacquelyn K. Patterson10, Edward A. Liechty11, Richard J. Derman12, Waldemar A. Carlo13,
William Petri14, Marion Elizabeth M. Koso‑ThomasMcClure15,2, Robert L. Goldenberg16, Patricia Hibberd17
and Nancy F. Krebs18

From Global Network Virtual. 3-15 Septemeber 2020

Abstract
Background: Quality assurance (QA) is a process that should be an integral part of research to protect the rights and
safety of study participants and to reduce the likelihood that the results are affected by bias in data collection. Most
QA plans include processes related to study preparation and regulatory compliance, data collection, data analysis and
publication of study results. However, little detailed information is available on the specific procedures associated with
QA processes to ensure high-quality data in multi-site studies.
Methods: The Global Network for Women’s and Children’s Health Maternal Newborn Health Registy (MNHR) is a
prospective population-based registry of pregnancies and deliveries that is carried out in 8 international sites. Since its
inception, QA procedures have been utilized to ensure the quality of the data. More recently, a training and certifica‑
tion process was developed to ensure that standardized, scientifically accurate clinical definitions are used consist‑
ently across sites. Staff complete a web-based training module that reviews the MNHR study protocol, study forms
and clinical definitions developed by MNHR investigators and are certified through a multiple choice examination
prior to initiating study activities and every six months thereafter. A standardized procedure for supervision and evalu‑
ation of field staff is carried out to ensure that research activites are conducted according to the protocol across all the
MNHR sites.
Conclusions: We developed standardized QA processes for training, certification and supervision of the MNHR, a
multisite research registry. It is expected that these activities, together with ongoing QA processes, will help to further
optimize data quality for this protocol.
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Plain english summary
All research studies should have quality assurance, as this
protects the rights and safety of study participants. It also
improves the quality of data collection and improves the
likelihood of obtaining true results. Most quality assurance plans cover a variety of topics, including the preparation prior to the study, ethics issues, analysis of data
and publication of study results. There is limited information on the procedures that different studies use to
ensure data of high quality.
The procedures that we report here were done as part
of the The Global Network for Women’s and Children’s
Health Maternal Newborn Health Registy (MNHR), registry of pregnancies and deliveries that is carried out in 8
international sites. The MNHR has adoptes quality assurance procedures since its beginning, to ensure the quality
of the data. More recently we developed a training and
certification process to ensure that the same clinical definitions be used across these eight sites. The study staff
are trained on these defitions with a web-based training
module which covers the study protocol, study forms and
clinical definitions. They are later certified before initiating study activities and every six months thereafter. The
MNHR also carries out a procedure for supervision and
evaluation of field staff to ensure that research activites
are conducted according to the protocol across all sites.
We expect that all of these activities will help to further
optimize data quality for this protocol.
Background
Quality assurance (QA) is a process that should be carried out throughout all phases of research to protect the
rights and safety of study participants, to improve consistency in data and to reduce the likelihood that trial
results are affected by bias [1, 2]. QA seeks to ensure
that studies comply with research standards, to detect
problems early through routine monitoring and to correct issues through prompt and effective action [3]. Such
processes should be considered a standard part of all
research activities.
Most QA plans include processes related to study preparation and regulatory compliance, data collection, data
analyses and publication of study results [1]. Additionally, multi-site studies generally include common variables, data collection methodologies and standardized
protocols. However, although there is consensus on the
importance of data quality for research, little detailed
information is available on the specific procedures and

best practices for QA processes [4]. One research study
from India recently published a data quality assurance
protocol, which focused on tools to ensure the accuracy,
reliability, timeliness, completeness, precision, and integrity of the data [5]. The investigators found that the tools
helped increase accuracy of data collection throughout
the research project. With the increasing global emphasis
on harmonization and data sharing in research, ensuring not only high quality of data but also comparability
of data across diverse settings is critical to accurate interpretation of findings [6, 7].
The Maternal Newborn Health Registry (MNHR) is a
prospective, population-based registry of pregnancies
and deliveries conducted under the auspices of the Global
Network for Women’s and Children’s Health Research
(GN), a multi-country research network. The MNHR
enrolls approximately 60,000 pregnant women each
year and follows them from early pregnancy through the
postnatal period [8, 9]. Briefly, its primary purpose is to
quantify and analyze trends in pregnancy outcomes over
time across the GN research sites. It also serves as a data
collection tool for capturing pregnancies, perinatal and
neonatal outcomes for individual studies [10, 11] and
provides data to plan future GN studies. Additionally,
MNHR data are frequently provided to local health officials who use it to inform and improve clinical care.
Because the MNHR operates in multiple sites in diverse
low and middle-income countries (LMIC) and collects
sensitive data on a large scale, QA has been particularly
integral to ensuring quality data collection since the
Registry’s inception in 2008. At the start of the MNHR,
the investigators determined the critical data to collect,
developed common definitions based on the WHO criteria, and also defined common methods to collect the
data. In addition, the MNHR introduced a process of
ongoing data quality monitoring, including metrics to
assess missingness and accuracy, which was conducted
both with local research teams and centrally, with a
process for rapid feedback and resolution of data issues
(Table 1) [12].
In 2017, in an effort to continously improve the quality
of data in the MNHR and to further ensure comparability across diverse sites, we identified a need to standardize the clinical data collected by field staff across all sites.
To address this gap, we developed additional procedures
for training, certification and supervision of all staff
within the MNHR. In this this paper, we describe the
development of tools to support the standardization and
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Table 1 Elements of the quality assurance plan for the Global Network’s Maternal and Newborn Health Registry
Study preparation and regulatory compliance

Institutional Review Board and Ethical Review Com‑
mittee approved protocol, consents and recruitment
materials
Curriculum vitaes and documentation of qualifications
of investigators
Case report forms
Staff traininga

Data collection

Standard operating procedures
Manual of operations
Monitoring plan
Supervisory visitsa

Data analysis

Monthly monitoring reports
Quarterly monitoring metrics
Data Monitoring Committee

a

Recently implemented QA procedures

enhanced QA of data collection including a web-based
standardized training and certification procedure and
an evaluation tool for consistent supervision of field staff
at all GN sites. Additionally, we describe our proposed
approach to evaluate the feasibility and effectiveness of
these newly-implemented procedures.

Methods
Setting and background

The GN MNHR was established in research sites based in
Argentina, Guatemala, India (two sites), Kenya, Pakistan
and Zambia [5]. A site in the the Democratic Republic of
the Congo (DRC) replaced the site in Argentina in 2013
and a Bangladeshi site was added in 2019. Investigators
from each participating site and a partner United Statesbased institution, the NICHD and the Data Coordinating Center (DCC) based at RTI International, comprise
the GN MNHR subcommittee that oversees all aspects
of protocol design, study implementation, data analyses
and publications. The GN MNHR is conducted under
the auspices of the GN, a multi-disciplinary research network, which is supported by research grants from the
National Institute of Child Health and Human Development (NICHD).
For each site, the Principal Investigator (PI; based at a
United States university), and the Senior Foreign Investigator (SFI; based at an international research site) are
collectively responsible for ensuring the overall quality
of the site’s data. A country coordinator (CC) provides
study oversight in the field; one or more study supervisors train and supervise registry administrators (RAs).
RAs have a variety of backgrounds, and have various
types and levels of professional training (i.e., midwives,
community health workers, physicians, nurses, medical technologists, health assistants, and social workers);
however, a minimal requirement is community health
worker level experience. They work with a wide range of

public and private providers and collect data in multiple
settings including participants´ homes and health institutions (Fig. 1). The RAs are paid study staff with participation in ongoing training considered part of their research
responsibilities.
QA procedures in place since the inception of the MNHR
Study preparation and regulatory compliance

In preparation for implementation of the MNHR, each
of the GN study sites obtained approval of the study protocol, consent and case report forms (CRFs) from their
respective Institutional Review Board both in the US
and in-country. All research staff were certified in the
Protection of Human Subjects and Good Clinical Practices. In accordance with NICHD policy, the study protocol, manual of procedures (MOP) and CRFs are publicly
available through the GN website (https://gn.rti.org/); deidentified study data is available for secondary analyses
through the NICHD Data and Specimen (N-DASH) hub
(https://dash.nichd.nih.gov/).
Data collection

Standard operating procedures for data collection are
detailed in the MNHR MOP which has been in place
since study inception; it is reviewed annually and updated
as needed. A question by question (QxQ) document
defines each study question and is updated as needed; a
policy document includes technical memos that describe
new study procedures and outlines the addition or elimination of variables.
Data processing, analysis and publication

All MNHR data are entered locally into a computerbased data management system (DMS) that incorporates inter and intra-form data quality checks. The DCC
produces monthly monitoring reports which detail site
and cluster specific metrics to identify issues related to
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Fig. 1 Maternal Newborn Health Registry study organization at site

completeness of data collection and to review changes
in outcomes measure quality improvements over time.
Specifically, the reports focus on critical data, as defined
by the central working group to ensure the completeness
and accuracy of those data elements. Each site reviews
these monthly monitoring reports and participates in
quarterly monitoring calls [8]. Study data are reviewed
annually by a Data Monitoring Committee. A publication management system outlines specific procedures for
publication of study results.
QA procedures

In an effort to continuously improve the quality of our
data collection, we developed a standardized training
and certification process for RAs as well as standardized
supervisory procedures.
Training and certification

To improve data collection, including the use of standardized clinical definitions, we developed a web-based,
interactive training module for MNHR RAs.
Development and pilot evaluation

Prior to developing the module, we developed standardized definitions for all clinical data collected in the
MNHR through an iterative process. First, we reviewed
the MNHR CRFs and identified all clinical data fields
(Table 2). We then conducted extensive searches for definitions of these terms using a variety of sources including
the WHO and United Nations Population Fund websites as well as technical documents, clinical textbooks
and peer reviewed journals. Based on these definitions,
we compiled draft definitions for the MNHR that were

reviewed by the GN MNHR subcommittee and study site
investigators, including obstetric and pediatric specialists in the GN, for scientific accuracy. The subcommittee further refined these definitions during an in-person
discussion to ensure they reflected the diagnostic capability of current healthcare at the MNHR research sites.
For example, the final MNHR definition for malaria does
not require confirmatory laboratory testing, as GN sites
with high malaria prevalence diagnose the disease clinically without routinely performing confirmatory laboratory testing. Similarly, the definition of neonatal sepsis
does not require confirmation with blood culture. Lastly,
a medical editor reviewed the final draft definitions,
also ensuring the literacy level was appropriate for the
level of medical training required of MNHR RAs. As the
next step, the modules were pilot tested with a sample of
learners from the sites. These staff provided feedback on
the definitions as well as the use of pictorial images.
Implementation of web‑based QA

Using these standardized clinical definitions, study protocol and MOP, the Instituto de Nutrición de Centro
América y Panamá (INCAP) developed a web-based
training module with Storyline 360 (https://360.articulate
.com) software, which supports the development of interactive courses for all types of computers and devices. This
training module was designed using andragogic learning principles for adults, facilitating knowledge acquisition by linking new concepts to previous experiences
and prior knowledge [13]. The course contextualizes the
learning process to the MNHR setting, so that learners
can establish an immediate link between theory (such
as clinical definitions) and its practical application. The
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Table 2 Clinical processes of care and health outcomes collected on Maternal and Newborn Health Registry forms, 2019
Pregnancy

Delivery

Postpartum and neonatal

Outcomes
Ectopic pregnancy
Miscarriage or spontaneous abortion
Induced abortion
Abortive related outcome
Malaria
Syphilis
Hypertensive disease/preeclampsia/eclampsiaa
Fetal or vaginal odor
Other maternal infection
Processes of care
Dilation and curetage or suction

Outcomes
Transverse lie
Oblique lie
Breech lie
Severe antepartum hemorrhagea
Obstructed/prolonged labor, failure to progress
Obstetric fistula
Severe postpartum hemorrhagea
Severe infection
Acute inversion of the uterus
Maternal deatha
Signs of maceration
Stroke/loss of consciousness/paralysis
Stillbirtha
Birth trauma/difficult delivery
Cord complication
Major malformation at birth
Processes of care
Unplanned hospitalization
Antibiotics
Corticosteroids
Oxytocin
Misoprostol
Magnesium Sulphate
Induction of labor
Episiotomy
Blood transfusion
Hysterectomy
Forceps/vacuum extraction delivery

Outcomes
Congenital anomalies
Abdominal wall defect
Neural tube defect
Breathing difficulties
Prematurity
Breathed weekly or did not cry at birth
Fits/seizures of the neonate fever or low
temperature chest X ray or clinical finding of
pneumonia
Pus draining from umbilical stump
Asphyxia (neonate)
Sepsis (neonate)
Accident/assault/trauma/suicide
Diabetes
Severe anemia
Severe jaundice
Infection
Seizures
Signs of fetal distress
Processes of care
Required resuscitation at birth
Continued positive airway pressure
Oxygen
Mechanical ventilation
Medicinal eye care
Medicinal cord care

a

Common to more than one period

module covers the study objectives, protocol, and CRFs
including instructions for use and standardized definitions for all clinical data fields.
This web-based module is available to all sites through
the GN webpage, which can be accessed through study
computers or tablets as well as in an off-line mode. The
module engages learners through key information and
communication technology. It was developed in English
and translated into Spanish and French, with subtitles
appearing throughout the course. If additional languages
are required, the local staff provide translations. Clinical definitions are communicated with multi-media,
using text, audio, and an image illustrating the concept.
Brief quizzes, which require matching the definition to
the concept after review of every three clinical terms,
are interspersed throughout the module to help learners
assess their comprehension. Finally, the course highlights
achievements of the learner as he/she completes each
section. Techincal assistance is provided centrally by RTI
staff, as needed, to complete the modules.
Following the training module, RAs complete a multiple-choice certification exam (available to all sites
through the GN webpage or via an electronic copy on
a storage device). Initial certification, and recertification, require a minimum score of 80% on this exam. If

an RA does not attain this score, he/she receives additional training from the country coordinator and repeats
the training module before re-taking the exam. All RAs
recertify by obtaining a passing grade on the certification
exam every six months. Additionally, RAs have access to
the module for additional training whenever necessary.
Altogether, the training and certification process takes
approximately 8–10 h for each staff to complete.
Supervisory visits

To improve data collection and study implementation,
the subcommittee also standardized supervisory procedures of RAs across sites.
First, each site submitted a description of their site-specific supervisory evaluation process, including any corresponding forms. Based on these descriptions and the
recommendations for implementation of QA processes,
the subcommittee developed a standardized supervisory
procedure with corresponding CRF for usage by all sites
in the MNHR. This CRF assesses general activities of the
RA, communication with other health providers and a
field visit, including a key variable check. Country coodinators piloted the supervisory process and forms in each
site. They informally found the proposed procedures and
frequency of supervision to be feasible. Additionally, they
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gave feedback on the data selected for variable checks
such as using maternal height instead of weight since the
latter can fluctuate between when an RA records the data
and a supervisor confirms it. Final variables were selected
based on their likelihood of being easily recalled by the
mother and readily obtained during a supervisory home
visit, and included such items as maternal height, delivery location, and mode of delivery.
The final, standardized supervisory procedure occurs
as follows:
Annually, all RAs undergo two supervisory visits consisting of three parts, which are recorded on a study
form. The supervisor arrives in the community where the
RA is scheduled and corroborates that he/she is prepared
with consents, study forms and equipment. The supervisor visits community level or ministry of health staff to
corroborate that the RA interfaces regularly and appropriately with them. Finally, the supervisor visits two randomly selected MNHR participants to corroborate data
in the DMS for specific key variables. Supervisors review
the findings of these supervision processes with each RA.
If necessary, RAs are provided additional training targeting non-compliance with study procedures or errors
in data collection through the training module or direct
coaching by supervisors.
Evaluation plan of recently implemented QA procedures

Country coordinators ensure that all RAs complete training and certification procedures and report on these processes to the DCC, which keeps a log of these data. Data
collected through the supervisory process are entered
into the DMS and analyzed by the DCC. Results of both
are discussed on periodic site calls.
To evaluate the impact of these QA methods, the subcommittee will review the training and certification procedure for feasibility (such as the number of RAs trained
and average time for course completion) and effectiveness (such as certification exam scores and first-time
pass rate). Through data collected during our supervisory procedure, we will evaluate RA fidelity to the study
protocol and quality of data collected (such as percent of
data elements in the DMS that is congruent with participant-reported data for each key variable). We will track
congruency of all key variables on the CRF over time
to determine whether our QA training is successful at
improving the quality of the data. Additionally, the central QA team reviews the content and updates, as needed,
on a bi-annual basis.

Discussion
QA is a necessary part of conducting research; best practices recommend that it includes measures to prevent,
detect and correct errors from the beginning of data
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collection through the publication of study results. QA
also helps ensure that data are accurate and collected
using common methods across sites. This is particularly
challenging in multi-site, large-scale studies such as the
MNHR. Multi-site studies need to ensure standardization of definitions across diverse settings to help ensure
generalizability of findings. In addition to the standardized definitions and procedures, other studies have
emphasized the importance of leveraging local capacity
with central technical support, similar to the model of
the GN [14, 15]. Additionally, as with the GN, the use of
ongoing data metrics in routine monitoring reports have
been shown to improve data quality [5, 16].
The MNHR includes participants in eight diverse
LMIC settings, enrolling approximately sixty thousand
participants annually. Since its inception ten years ago,
we designed QA procedures for data collection, entry,
editing and transmission. In 2012, we added metrics
and standardized reports to facilitate regular identification of site-specific implementation issues. These QA
procedures have supported the successful enrollment of
704,265 participants with over 95% followed from pregnancy through delivery [9].
Building upon the existing platform of common definitions and ongoing data monitoring, in an effort to continuously improve the quality of our data in 2017 we
implemented standardized training and certification as
well as supervisory procedures with a number of notable strengths. Our training and certification procedure
includes newly-developed, standardized definitions for
all clinical data collected in the MNHR. The web-based
training module utilizes andragogic learning principles
and capitalizes on information and communication technology to engage learners. Recertification of RAs ensures
that initial proficiency in study procedures is maintained.
The supervisory procedure facilitates the detection of
non-compliance with study procedures as well as errors
in data collection, reporting and entry. All GN sites have
successfully implemented these training, certification
and supervisory procedures, and given the relatively low
additional burden in terms of time and other resources,
have found that they are feasible to continue. We thus
view these changes in procedures to be strengths that
will enhance the utility of this registry for its multiple
intended purposes.
Despite these strengths, there are limitations to our
newly-implemented QA procedures. The MNHR data
are collected via medical record abstraction and interview of participants. While we developed standardized
clinical definitions to support accurate data collection,
these definitions do not ensure accurate ascertainment
and documentation of clinical diagnoses by health care
providers, nor do they ensure accurate maternal recall.
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Similarly, while we attempted to verify variables most
likely to be recalled by the mother during supervisory
visits, maternal recall is an imperfect ‘gold standard’.
In this manuscript, we have described a comprehensive QA procedure that may serve as a model for other
multi-site large-scale studies. Through routine MNHR
review processes, we identified an opportunity to
improve training and oversight with the goal of assuring strong adherence to a protocol implemented in
diverse low resource settings. On-going data collection
regarding these processes will allow us to evaluate their
feasibility and effectiveness, and to determine critical
elements for maintaining high quality data for this and
other similar registry—based protocols.

Conclusion
In conclusion, especially for large, multi-site clinical research studies in LMICs, the ability to harmonize data across diverse settings presents challenges,
limiting the ability to compare site results. Providing a standardized training across the sites together
with reinforced supervision and oversight that is centrally monitored has proven useful in improving quality of data. The approaches used to facilite QA across
the MNHR have applicability across other multi-site
research studies, which have particular challenges in
ensuring common methodologies and interpretation of
data.
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